Young-onset lung cancer registry and dedicated care program impact on patient experience
Registry Trial and Needs Assessment of Patients With Young-onset Lung Cancer: Impact of a Dedicated Care Program on Patient Experience and Outcomes
This project will see if enrolling adults under 50 with non-small cell lung cancer in a dedicated care program and peer support networks improves their satisfaction, quality of life, and related outcomes.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 75 (estimated) |
| Ages | 18 Years to 50 Years |
| Sex | All |
| Sponsor | M.D. Anderson Cancer Center Academic / other |
| Locations | 1 site (Houston, Texas) |
| Trial ID | NCT07220096 on ClinicalTrials.gov |
What this trial studies
This observational registry enrolls adults aged 18–49 with histologically confirmed non-small cell lung cancer to collect survey and clinical data over time. Researchers compare patients enrolled in the Young-Onset Lung Cancer (YOLC) program to others to examine patient satisfaction, quality of life (FACT-LUNG), needs of patients and families, peer support participation, clinical trial enrollment, multidisciplinary consultations, overall survival, and financial impacts. Participation involves completing periodic English-language surveys and providing clinical outcome data, with exclusions for those unable to consent or complete surveys. Data will be used to characterize unmet needs and the association between program enrollment or peer support participation and patient-centered and clinical outcomes.
Who should consider this trial
Good fit: Adults aged 18–49 with histologically confirmed non-small cell lung cancer who can complete English-language surveys (alone or with interpreter help) are the ideal candidates.
Not a fit: Individuals outside the 18–49 age range, with non-NSCLC diagnoses, with cognitive or psychiatric conditions that prevent informed consent or survey completion, or who cannot engage with the program or peer support are unlikely to benefit.
Why it matters
Potential benefit: If successful, the program could improve patient satisfaction and quality of life for younger adults with lung cancer and inform services to better meet patients' and families' needs.
How similar studies have performed: Related observational programs and patient-navigation or peer-support initiatives in oncology have shown improvements in satisfaction and quality of life, but rigorous evidence specifically in young-onset lung cancer remains limited.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age greater than 18 years and under 50 years * Histologic confirmation of NSCLC * Able to complete an English-language survey independently or with the assistance of a native-language interpreter * Pregnant women- may be enrolled due to age range of subjects. (Low risk) Exclusion Criteria: * Medical, psychiatric, cognitive, or other conditions that compromise the patient's ability to understand the patient information, to give informed consent, to comply with the study protocol or to complete the study. * The following special patient population will be excluded from study group: * Individuals who are not yet adults (infants, children, teenagers) * Prisoners * Cognitively-impaired adults
Where this trial is running
Houston, Texas
- The University of Texas M. D. Anderson Cancer Center — Houston, Texas, United States (Recruiting)
Study contacts
- Principal investigator: Eric Singhi, MD — M.D. Anderson Cancer Center
- Study coordinator: Eric Singhi, MD
- Email: eksinghi@mdanderson.org
- Phone: 713-745-2263
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.